Concepedia

John R. McCullough

JR

20

Publications

1K

Citations

16

H-Index

1975

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Sunovion (United States)

University of Massachusetts Chan Medical School

State University of New York

John R. McCullough is an author at Bristol-Myers Squibb (United States) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1975–2000

20

Publications

20

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.

G. J. Grover, John R. McCullough, D E Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 177 citations

Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.

John R. McCullough, Diane E. Normandin, Mary Lee Conder et al. · Circulation Research · 1991 · 138 citations

, , +18

(S)-Albuterol Increases Intracellular Free Calcium by Muscarinic Receptor Activation and a Phospholipase C-Dependent Mechanism in Airway Smooth Muscle

Sankar Mitra, Mehmet Uğur, Özlem Uğur et al. · Molecular Pharmacology · 1998 · 115 citations

Comparison ofR-, S-, andRS-albuterol interaction with human β1 and β2-adrenergic receptors

Raymond B. Penn, Thomas Frielle, John R. McCullough et al. · Clinical Reviews in Allergy & Immunology · 1996 · 111 citations

, , +9

Cardioprotective Profile of the Cardiac-Selective ATP-Sensitive Potassium Channel Opener BMS-180448

Gary J. Grover, John R. McCullough, Albert J. DʼAlonzo et al. · Journal of Cardiovascular Pharmacology · 1995 · 65 citations

Rows per page

1–5 of 20